Current issue
About the Journal
Scientific Council
Editorial Board
Regulatory and archival policy
Code of publishing ethics
Publisher
Information about the processing of personal data in relation to cookies and newsletter subscription
Archive
For Authors
For Reviewers
Contact
Reviewers
Annals reviewers in 2023
Annals reviewers in 2022
Annals reviewers in 2021
Annals reviewers in 2020
Annals reviewers in 2019
Annals reviewers in 2018
Annals reviewers in 2017
Annals reviewers in 2016
Annals reviewers in 2015
Annals reviewers in 2014
Annals reviewers in 2013
Annals reviewers in 2012
Links
Sklep Wydawnictwa SUM
Biblioteka Główna SUM
Śląski Uniwersytet Medyczny w Katowicach
Privacy policy
Accessibility statement
Reviewers
Annals reviewers in 2023
Annals reviewers in 2022
Annals reviewers in 2021
Annals reviewers in 2020
Annals reviewers in 2019
Annals reviewers in 2018
Annals reviewers in 2017
Annals reviewers in 2016
Annals reviewers in 2015
Annals reviewers in 2014
Annals reviewers in 2013
Annals reviewers in 2012
Streptococcus pyogenes sepsis in 32-year-old man as rare complication of bacterial pharyngitis
1
Department of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
2
Department of Internal Medicine, Angiology and Physical Medicine,
Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
3
Department of Internal Medicine, Metabolic Diseases and Angiology, Faculty of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland
Corresponding author
Grzegorz K. Jakubiak
Katedra i Zakład Farmakologii, Śląski Uniwersytet Medyczny w Katowicach, ul. Jordana 38, 41-808 Zabrze
Katedra i Zakład Farmakologii, Śląski Uniwersytet Medyczny w Katowicach, ul. Jordana 38, 41-808 Zabrze
Ann. Acad. Med. Siles. 2025;79:29-35
KEYWORDS
TOPICS
ABSTRACT
Group A beta-hemolytic streptococci (Streptococcus pyogenes – S. pyogenes) are the etiological factor of a wide range of infections, primarily pharyngitis, inflammation of the skin and subcutaneous tissue, as well as invasive infections. They can also lead to immunological complications, such as acute glomerulonephritis, rheumatic fever, and rheumatic heart disease. Although S. pyogenes may be the etiological factor for sepsis, sepsis of this etiology is rarely observed as a complication of upper respiratory tract infections in clinical practice. The aim of this paper is to present a case report of a 32-year-old man, previously untreated for chronic diseases, who was hospitalized for sepsis caused by S. pyogenes, which was a complication of an upper respiratory tract infection. As a result of targeted treatment with benzyl penicillin, significant improvement in the clinical condition of the patient and normalization of the inflammatory parameters were achieved. Due to a significant increase in the cardiac troponin serum concentration during hospitalization, the diagnostics were extended to include evaluation of the cardiovascular system.
REFERENCES (21)
1.
Huerta L.E., Rice T.W. Pathologic difference between sepsis and bloodstream infections. J. Appl. Lab. Med. 2019; 3(4): 654–663, doi: 10.1373/jalm.2018.026245.
2.
Kellum J.A., Formeck C.L., Kernan K.F., Gómez H., Carcillo J.A. Subtypes and mimics of sepsis. Crit. Care Clin. 2022; 38(2): 195–211, doi: 10.1016/j.ccc.2021.11.013.
3.
Grondman I., Pirvu A., Riza A., Ioana M., Netea M.G. Biomarkers of inflammation and the etiology of sepsis. Biochem. Soc. Trans. 2020; 48(1): 1–14, doi: 10.1042/BST20190029.
4.
Abushaheen M.A., Muzaheed, Fatani A.J., Alosaimi M., Mansy W., George M. et al. Antimicrobial resistance, mechanisms and its clinical significance. Dis. Mon. 2020; 66(6): 100971, doi: 10.1016/j.disamonth.2020.100971.
5.
van den Berg M., van Beuningen F.E., Ter Maaten J.C., Bouma H.R. Hospital-related costs of sepsis around the world: A systematic review exploring the economic burden of sepsis. J. Crit. Care 2022; 71: 154096, doi: 10.1016/j.jcrc.2022.154096.
6.
Zaccone V., Tosoni A., Passaro G., Vallone C.V., Impagnatiello M., Li Puma D.D. et al. Sepsis in internal medicine wards: current knowledge, uncertainties and new approaches for management optimization. Ann. Med. 2017; 49(7): 582–592, doi: 10.1080/07853890.2017.1332776.
7.
Wang J., Ma C., Li M., Gao X., Wu H., Dong W. et al. Streptococcus pyogenes: pathogenesis and the current status of vaccines. Vaccines (Basel) 2023; 11(9): 1510, doi: 10.3390/vaccines11091510.
8.
Valderrama J.A., Riestra A.M., Gao N.J., LaRock C.N., Gupta N., Ali S.R. et al. Group A streptococcal M protein activates the NLRP3 inflammasome. Nat. Microbiol. 2017; 2(10): 1425–1434, doi: 10.1038/s41564-017-0005-6.
9.
Blöchl C., Holzner C., Luciano M., Bauer R., Horejs-Hoeck J., Eckhard U. et al. Proteolytic profiling of streptococcal pyrogenic exotoxin B (SpeB) by complementary HPLC-MS approaches. Int. J. Mol. Sci. 2021; 23(1): 412, doi: 10.3390/ijms23010412.
10.
Jain M., Teçza M., Kagawa T.F., Cooney J.C. Exosite binding modulates the specificity of the immunomodulatory enzyme ScpA, a C5a inactivating bacterial protease. Comput. Struct. Biotechnol. J. 2022; 20: 4860–4869, doi: 10.1016/j.csbj.2022.08.018.
11.
Bryant A.E., Bayer C.R., Chen R.Y., Guth P.H., Wallace R.J., Stevens D.L. Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. J. Infect. Dis. 2005; 192(6): 1014–1022, doi: 10.1086/432729.
12.
Kurupati P., Turner C.E., Tziona I., Lawrenson R.A., Alam F.M., Nohadani M. et al. Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract. Mol. Microbiol. 2010; 76(6): 1387–1397, doi: 10.1111/j.1365-2958.2010.07065.x.
13.
Catton E.A., Bonsor D.A., Herrera C., Stålhammar-Carlemalm M., Lyndin M., Turner C.E. et al. Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesis. Nat. Commun. 2023; 14(1): 2275, doi: 10.1038/s41467-023-37732-1.
14.
Chadha A., Jamal W., Aziz A.R.A., Rotimi V.O. Overwhelming Streptococcus pyogenes sepsis in an elderly patient with septic arthritis. J. Infect. Public Health 2018; 11(3): 434–435, doi: 10.1016/j.jiph.2017.08.011.
15.
Holt M., Zerden M. Adolescent primary genital herpes simplex virus type 1 infection with sepsis secondary to Streptococcus pyogenes bacteremia. J. Pediatr. Adolesc. Gynecol. 2022; 35(1): 91–93, doi: 10.1016/j.jpag.2021.07.001.
16.
Szczypa K., Wilemska J., Hryniewicz W., Sitkiewicz I. Epidemiology of Streptococcus pyogenes infections, clonal structure population and antibiotic resistance. [Article in Polish]. Post. Mikrobiol. 2013; 52(3): 223–232.
17.
Walker M.J., Barnett T.C., McArthur J.D., Cole J.N., Gillen C.M., Henningham A. et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin. Microbiol. Rev. 2014; 27(2): 264–301, doi: 10.1128/CMR.00101-13.
18.
Smeesters P.R., de Crombrugghe G., Tsoi S.K., Leclercq C., Baker C., Osowicki J. et al. Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic review. Lancet Microbe 2024; 5(2): e181–e193, doi: 10.1016/S2666-5247(23)00318-X.
19.
Jakubiak G.K. Cardiac troponin serum concentration measurement is useful not only in the diagnosis of acute cardiovascular events. J. Pers. Med. 2024; 14(3): 230, doi: 10.3390/jpm14030230.
20.
Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 2005; 5(11): 685–694, doi: 10.1016/S1473-3099(05)70267-X.
21.
Stec M., Suleja A., Kuczmik W., Mroskowiak A., Migacz M., Holecki M. Comparison of course of infections and antibiotherapy in patients with and without diabetes mellitus – one center experience. Ann. Acad. Med. Siles. 2023; 77: 217–225, doi: 10.18794/aams/166423.
| eISSN: | 1734-025X |
The Medical University of Silesia in Katowice, as the Operator of the annales.sum.edu.pl website, processes personal data collected when visiting the website. The function of obtaining information about Users and their behavior is carried out by voluntarily entered information in forms, saving cookies in end devices, as well as by collecting web server logs, which are in the possession of the website Operator. Data, including cookies, are used to provide services in accordance with the Privacy policy.
You can consent to the processing of data for these purposes, refuse consent or access more detailed information.
You can consent to the processing of data for these purposes, refuse consent or access more detailed information.
